Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fphar.2020.01196 http://scihub22266oqcxt.onion/10.3389/fphar.2020.01196 32848795!7424051!32848795     free     free     free       Front+Pharmacol 2020 ; 11 (ä): 1196 Nephropedia Template TP {{tp|p=32848795|t=2020. COVID-19 Therapeutic Options Under Investigation |pdf=|usr=}}{{32848795}} gab.com Text COVID-19 Therapeutic Options Under Investigation JO: Front Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=32848795 #FOAvip Since its emergence in China in December 2019, COVID-19 has quickly spread around the globe causing a pandemic. Vaccination or the development of herd immunity seems the only way to slow down the spread of the virus; however, both are not achievable in the near future. Therefore, effective treatments to mitigate the burden of this pandemic and reduce mortality rates are urgently needed. Preclinical and clinical studies of potential antiviral and immunomodulatory compounds and molecules to identify safe and efficacious therapeutics for COVID-19 are ongoing. Two compounds, remdesivir, and dexamethasone have been so far shown to reduce COVID-19-associated death. Here, we provide a review of the potential therapeutic agents being considered for the treatment and management of COVID-19 patients. Twit Text FOAVip COVID-19 Therapeutic Options Under Investigation ????Front Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=32848795 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32848795 #FOAvip English Wikipedia <ref>{{Cite pmid|32848795}}</ref> COVID-19 Therapeutic Options Under Investigation #MMPMID32848795 Kaddoura M; AlIbrahim M; Hijazi G; Soudani N; Audi A; Alkalamouni H; Haddad S; Eid A; Zaraket H Front Pharmacol 2020[]; 11 (ä): 1196 PMID32848795show ga Since its emergence in China in December 2019, COVID-19 has quickly spread around the globe causing a pandemic. Vaccination or the development of herd immunity seems the only way to slow down the spread of the virus; however, both are not achievable in the near future. Therefore, effective treatments to mitigate the burden of this pandemic and reduce mortality rates are urgently needed. Preclinical and clinical studies of potential antiviral and immunomodulatory compounds and molecules to identify safe and efficacious therapeutics for COVID-19 are ongoing. Two compounds, remdesivir, and dexamethasone have been so far shown to reduce COVID-19-associated death. Here, we provide a review of the potential therapeutic agents being considered for the treatment and management of COVID-19 patients. äCOVID-19 Therapeutic Options Under Investigation (epmc).pdf DeepDyve Pubget Overpricing